{
  "pmid": "PMID:32406525",
  "title": "Autism and attention-deficit/hyperactivity disorders and symptoms in children with neurofibromatosis type 1.",
  "abstract": "AIM: To evaluate if autism symptoms and diagnoses are more common in children with neurofibromatosis type 1 (NF1) than in typically developing children, to which levels, and to determine if co-occurring attention-deficit/hyperactivity disorder (ADHD) symptomatology accounts for this increase. METHOD: We searched hospital electronic medical records (EMR) for International Classification of Diseases, 10th Revision NF1 and co-occurring diagnoses codes. We recruited a subsample of 45 children (mean age 9y 2mo; SD 2y 7mo; range 5-12y; 22 males, 23 females) and collected parental reports of autism symptomatology, adaptive behavior, and behavioral problems that were compared to those of 360 age- and sex-matched controls from the Simons Simplex Collection (SSC) with autism spectrum disorder (ASD; SSC-ASD) or typically developing (SSC-TD). RESULTS: The EMR search identified 968 children with NF1; 8.8% had ADHD and 2.1% had ASD co-occurring diagnoses. In the subsample, the mean autism scale score for participants with NF1 was below cut-off for significant autism symptoms. Participants with NF1 had significantly more autism and behavioral symptoms than SSC-TD participants, and significantly less than SSC-ASD participants, with one exception: ADHD symptom levels were similar to those of SSC-ASD participants. In analyses that controlled for internalizing, ADHD, and communication scores, the difference in autism symptom levels between participants with NF1 and typically developing controls disappeared almost entirely. INTERPRETATION: Our results do not support an association between NF1 and autism, both at the symptom and disorder levels. WHAT THIS PAPER ADDS: Diagnoses of attention-deficit/hyperactivity disorder (ADHD) were more common in children with neurofibromatosis type 1 (NF1) than in the general child population. Diagnoses of autism spectrum disorder were no more common in children with NF1 than in the general child population. Increases in autism symptoms did not reach clinically significant thresholds. Co-occurring ADHD symptoms accounted for increased autism questionnaire scores. Adaptive behavior in participants with NF1 showed normal socialization but lower communication proficiency. OBJETIVO: Evaluar si el diagn\u00f3stico y los s\u00edntomas de autismo son m\u00e1s frecuentes en ni\u00f1os con neurofibromatosis tipo 1 (NF1) comparado a ni\u00f1os con desarrollo t\u00edpico, cu\u00e1les son los niveles de severidad, y determinar si la sintomatolog\u00eda concurrente debido d\u00e9ficit de atenci\u00f3n / hiperactividad (TDAH) explica la frecuencia. M\u00c9TODO: Se realizaron b\u00fasquedas en los registros m\u00e9dicos electr\u00f3nicos hospitalarios (EMR) para el diagn\u00f3stico de NF1 y c\u00f3digos concurrentes en la Clasificaci\u00f3n Internacional de Enfermedades, 10ma revisi\u00f3n. Reclutamos una submuestra de 45 ni\u00f1os (edad promedio 9 a\u00f1os 2 meses; DE 2 a\u00f1os 7 meses; rango 5-12 a\u00f1os; 22 varones y 23 mujeres). Recolectamos informes parentales acerca de la sintomatolog\u00eda del autismo, comportamiento adaptativo y problemas de conducta que se compararon con los de 360 ni\u00f1os pareados por edad y sexo provenientes de la Colecci\u00f3n Simons Simplex (SSC) de ni\u00f1os con trastorno del espectro autista (SSC-ASD) o de ni\u00f1os con desarrollo t\u00edpico (SSC-TD). RESULTADOS: La b\u00fasqueda de EMR identific\u00f3 a 968 ni\u00f1os con NF1; 8,8% ten\u00edan TDAH y 2,1% ten\u00edan diagn\u00f3sticos concurrentes de trastorno del espectro autista. En la submuestra de participantes con NF1, la media de puntaje de la escala de autismo fue inferior punto de corte. Los participantes con NF1 tuvieron significativamente m\u00e1s s\u00edntomas de autismo y problemas de conducta que los participantes de SSC-TD, y significativamente menos que los participantes de SSC-ASD. Hubo una excepci\u00f3n: los niveles de s\u00edntomas de TDAH fueron similares a los de los participantes de SSC-ASD. En los an\u00e1lisis que controlaron los s\u00edntomas internalizantes, el TDAH y los puntajes de comunicaci\u00f3n, la diferencia en los niveles de s\u00edntomas de autismo entre los participantes con NF1 y los controles con desarrollo t\u00edpico desaparecieron casi por completo. INTERPRETACI\u00d3N: Nuestros resultados no respaldan una asociaci\u00f3n entre NF1 y autismo, tanto a nivel de frecuencia de los s\u00edntomas, ni con la severidad de los mismos. OBJETIVO: Avaliar se sintomas e diagn\u00f3stico de autismo s\u00e3o mais comuns em crian\u00e7as com neurofibromtose tipo 1 (NF1) do que em crian\u00e7as com desenvolvimento t\u00edpico, em quais n\u00edveis, e determinar se co-ocorr\u00eancia de sintomatologia do transtorno do d\u00e9ficit de aten\u00e7\u00e3o e hiperatividade (TDAH) explica este aumento. M\u00c9TODO: Pesquisamos registros m\u00e9dicos eletr\u00f4nicos (RME) hospitalares quanto aos c\u00f3digos diagn\u00f3sticos de NF1 e diagn\u00f3sticos co-ocorrentes segundo a Classifica\u00e7\u00e3o Internacional de Doen\u00e7as, 10\u00aa revis\u00e3o. Recrutamos uma sub-amostra de 45 crian\u00e7as (m\u00e9dia de idade 9a 2m; DP 2a 7m; varia\u00e7\u00e3o 5-12a; 22 do sexo masculino, 23 do sexo feminino) e coletamos relatos parentais de sintomatologia de autismo, comportamento adaptativo, e problemas comportamentais quer foram comparados com os 360 controles pareados por sexo e idade da Simons Simplex Collection (SSC) com transtorno do espectro autista (TEA; SSC-TEA) ou desenvolvimento t\u00edpico (SSC-DT). RESULTADOS: A busca em RME identificou 968 crian\u00e7as com NF1; 8,8% tinha TDAH e 2,1% tinha diagn\u00f3stico concomitante de TEA. Na sub-amostra, o escore m\u00e9dio de autismo para os participantes com NF1 estava abaixo do ponto de corte para sintomas autistas significantes. Os participantes com NF1 tiveram significativamente mais sintomas de autismo e comportamento do que os participantes SSC-DT, e significativamente menos do que os participantes SSC-TEA, com uma exce\u00e7\u00e3o: os n\u00edveis de sintomas de TDAH foram similares aos participantes SSC-TEA. Na an\u00e1lise que controlou para escores internalizantes, TDAH e comunica\u00e7\u00e3o, a diferen\u00e7a nos n\u00edveis de sintomas autistas entre participantes com NF1 e desenvolvimento t\u00edpico desapareceu quase totalmente. INTERPRETA\u00c7\u00c3O: Nossos resultados n\u00e3o suportam associa\u00e7\u00e3o entre NF1 e autismo, mas com os sintomas e n\u00edveis de desordem.",
  "authors": "Hadley Morotti; Sarah Mastel; Kory Keller; Rebecca A Barnard; Trevor Hall; Brian J O'Roak; Eric Fombonne",
  "journal": "Developmental medicine and child neurology",
  "publicationDate": "2021-02",
  "doi": "10.1111/dmcn.14558",
  "methods": "",
  "cache_level": "abstract_only",
  "has_fulltext": false,
  "fetch_date": "2026-02-19 09:28:15"
}